Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol. 2016;22(2):286-291.   Published online 2016 Jun 25     DOI: https://doi.org/10.3350/cmh.2015.0066
Citations to this article as recorded by Crossref logo
Effect of tenofovir on renal function in patients with chronic hepatitis B
Woo Jin Jung, Jae Young Jang, Won Young Park, Soung Won Jeong, Hee Jeong Lee, Sang Joon Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Baigal Baymbajav
Medicine.2018; 97(7): e9756.     CrossRef
Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients
H. J. Tsai, Y. W. Chuang, S. W. Lee, C. Y. Wu, H. Z. Yeh, T. Y. Lee
Alimentary Pharmacology & Therapeutics.2018; 47(12): 1673.     CrossRef
Tenofovir disoproxil fumarate
Reactions Weekly.2016; 1617(1): 214.     CrossRef